Efficacy and safety of adalimumab (HUMIRA®) in European clinical practice:: The react trial

被引：0
|
作者：
Burmester, GR
Sáez, IM
Malaise, M
da Silva, JC
Webber, DG
Kupper, H
机构：
[1] Humboldt Univ, Univ Klinikum Charite, Berlin, Germany
[2] HGU Gregorio Maranon, Madrid, Spain
[3] CHU, Liege, Belgium
[4] Hosp Garcia Orta, Serv Reumatol, Almada, Portugal
[5] Abbott GmbH & Co KG, Immunosci, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [31] Dose Escalation of Adalimumab (Humira®) in Patients with Crohn's Disease in Routine Clinical Practice in Quebec
    Monfared, Amir Abbas Tahami
    Fan, Tao
    Sen, Shuvayu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S180 - S180
  • [32] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
    Su, Jinmei
    Li, Mengtao
    He, Lan
    Zhao, Dongbao
    Wan, Weiguo
    Liu, Yi
    Xu, Jianhua
    Xu, Jian
    Liu, Huaxiang
    Jiang, Lindi
    Wu, Huaxiang
    Zuo, Xiaoxia
    Huang, Cibo
    Liu, Xiumei
    Li, Fen
    Zhang, Zhiyi
    Liu, Xiangyuan
    Dong, Lingli
    Li, Tianwang
    Chen, Haiying
    Li, Jingyang
    He, Dongyi
    Lu, Xin
    Huang, Anbin
    Tao, Yi
    Wang, Yanyan
    Zhang, Zhuoli
    Wei, Wei
    Li, Xiaofeng
    Zeng, Xiaofeng
    BIODRUGS, 2020, 34 (03) : 381 - 393
  • [33] Effectiveness of adalimumab (Humira) in clinical practice: Results from the ACCLAIM study in patients with psoriatic arthritis
    Gladman, D. D.
    Wong, R. L.
    Guerette, B.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1185 - 1186
  • [34] Clinical remission in patients with psoriatic arthritis (PsA) treated with adalimumab (humira®). results of the stereo trial
    Van den Bosch, F.
    Manger, B.
    Goupille, P.
    McHugh, N.
    Kron, M.
    Kary, S.
    Kupper, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 743 - 743
  • [35] Adalimumab (HUMIRA®) is effective and safe in treating psoriatic arthritis (PsA) in real-life clinical practice:: Preliminary results of the STEREO trial.
    Van den Bosch, F.
    Reece, R.
    Manger, B.
    Goupille, P.
    Roedevand, E.
    Holck, P.
    FitzGerald, O.
    Van Vollenhoven, R.
    Leirisalo-Repo, M.
    Kron, M.
    Frank, M.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S719 - S720
  • [36] Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
    Schiff, M. H.
    Burmester, G. R.
    Kent, J. D.
    Pangan, A. L.
    Kupper, H.
    Fitzpatrick, S. B.
    Donovan, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 889 - 894
  • [37] Efficacy of Adalimumab in Refractory Ulcerative Colitis in Clinical Practice
    Lequoy, Marie
    Seksik, Philippe
    Bouhnik, Yoram
    Allez, Matthieu
    Carbonnel, Franck
    Bourrier, Anne
    Sokol, Harry
    Beaugerie, Laurent
    Cosnes, Jacques
    GASTROENTEROLOGY, 2013, 144 (05) : S203 - S203
  • [38] Biogen's Adalimumab IMRALDI - a Biosimilar to Humira® - is approved in the European Union
    不详
    VISCERAL MEDICINE, 2017, 33 (05) : 390 - 390
  • [39] Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial
    Vandenbosch, F.
    McHugh, N. J.
    Reece, R.
    Cooper, R.
    Manger, B.
    Goupille, P.
    FitzGerald, O.
    Kron, M.
    Frank, M.
    Kupper, H.
    Roedevand, E.
    Holck, P.
    VanVollenhoven, R.
    Leirisalo-Repo, M.
    RHEUMATOLOGY, 2007, 46 : I52 - I53
  • [40] Improvement of the individual ACR components in ACR20 responders in an adalimumab (HUMIRA™) RA clinical trial
    Furst, DE
    Weinblatt, ME
    Kavanaugh, A
    Kalden, JR
    Wells, AF
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S106 - S107
12345